Nomograms for postsurgical extrahepatic recurrence prediction of hepatocellular carcinoma based on presurgical circulating tumor cell status and clinicopathological factors

Abstract Background and Aims Extrahepatic recurrence (EHR) is one of the major reasons for the poor prognosis of hepatocellular carcinoma (HCC). The present study aimed to develop and assess the performance of predictive models by using a combination of presurgical circulating tumor cell (CTCs) data...

Full description

Bibliographic Details
Main Authors: Hao‐Wen Wei, Shui‐Ling Qin, Jing‐Xuan Xu, Yi‐Yue Huang, Yuan‐Yuan Chen, Liang Ma, Lu‐Nan Qi
Format: Article
Language:English
Published: Wiley 2023-07-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.6178
_version_ 1797744819833929728
author Hao‐Wen Wei
Shui‐Ling Qin
Jing‐Xuan Xu
Yi‐Yue Huang
Yuan‐Yuan Chen
Liang Ma
Lu‐Nan Qi
author_facet Hao‐Wen Wei
Shui‐Ling Qin
Jing‐Xuan Xu
Yi‐Yue Huang
Yuan‐Yuan Chen
Liang Ma
Lu‐Nan Qi
author_sort Hao‐Wen Wei
collection DOAJ
description Abstract Background and Aims Extrahepatic recurrence (EHR) is one of the major reasons for the poor prognosis of hepatocellular carcinoma (HCC). The present study aimed to develop and assess the performance of predictive models by using a combination of presurgical circulating tumor cell (CTCs) data and clinicopathological features to screen patients at high risk of EHR to achieve precise decision‐making. Patients and Methods A total of 227 patients with recurrent HCC and preoperative CTC data from January 2014 to August 2019 were enrolled. All patients were randomly assigned to one of two cohorts: development or validation. Two preoperative and postoperative nomogram models for EHR prediction were developed and multi‐dimensionally validated. Results Patients with EHR had generally lower recurrence‐free survival (p < 0.001), and overall survival (p < 0.001), and significantly higher CTC counts (epithelial CTCs, epithelial/mesenchymal hybrid CTCs, and mesenchymal CTCs count, all p < 0.05) than those without EHR. Univariate and multivariate analyses revealed that EHR was associated with four risk factors in the development cohort: total CTC count (p = 0.014), tumor size (p = 0.028), node number (p = 0.045), and microvascular invasion (p = 0.035). These factors were incorporated into two nomogram models (preoperative and postoperative), which reliably predicted EHR through multidimensional verification (e.g., calibration plot, receiver operating characteristic analysis, decision curve analysis, and clinical impact curve analysis) in the development and validation cohorts, respectively. With threshold of scores of 100.3 and 176.8 before and after surgery respectively, both nomograms were able to stratify patients into two distinct prognostic subgroups (all p < 0.05). Conclusion The present study proposed two nomogram models integrating presurgical CTC counts and clinicopathological risks and showed relatively good predictive performance of EHR, which may be beneficial to the clinical practice of HCC recurrence. Further multicenter studies are needed to assess its general applicability.
first_indexed 2024-03-12T15:14:44Z
format Article
id doaj.art-2073caa4bc724cc89f4404e731ae9b77
institution Directory Open Access Journal
issn 2045-7634
language English
last_indexed 2024-03-12T15:14:44Z
publishDate 2023-07-01
publisher Wiley
record_format Article
series Cancer Medicine
spelling doaj.art-2073caa4bc724cc89f4404e731ae9b772023-08-11T14:51:17ZengWileyCancer Medicine2045-76342023-07-011214150651507810.1002/cam4.6178Nomograms for postsurgical extrahepatic recurrence prediction of hepatocellular carcinoma based on presurgical circulating tumor cell status and clinicopathological factorsHao‐Wen Wei0Shui‐Ling Qin1Jing‐Xuan Xu2Yi‐Yue Huang3Yuan‐Yuan Chen4Liang Ma5Lu‐Nan Qi6Department of Hepatobiliary Surgery Guangxi Medical University Cancer Hospital Nanning ChinaDepartment of Hepatobiliary Surgery Guangxi Medical University Cancer Hospital Nanning ChinaDepartment of Hepatobiliary Surgery Guangxi Medical University Cancer Hospital Nanning ChinaDepartment of Hepatobiliary Surgery Guangxi Medical University Cancer Hospital Nanning ChinaDepartment of Ultrasound First Affiliated Hospital of Guangxi Medical University Nanning ChinaDepartment of Hepatobiliary Surgery Guangxi Medical University Cancer Hospital Nanning ChinaDepartment of Hepatobiliary Surgery Guangxi Medical University Cancer Hospital Nanning ChinaAbstract Background and Aims Extrahepatic recurrence (EHR) is one of the major reasons for the poor prognosis of hepatocellular carcinoma (HCC). The present study aimed to develop and assess the performance of predictive models by using a combination of presurgical circulating tumor cell (CTCs) data and clinicopathological features to screen patients at high risk of EHR to achieve precise decision‐making. Patients and Methods A total of 227 patients with recurrent HCC and preoperative CTC data from January 2014 to August 2019 were enrolled. All patients were randomly assigned to one of two cohorts: development or validation. Two preoperative and postoperative nomogram models for EHR prediction were developed and multi‐dimensionally validated. Results Patients with EHR had generally lower recurrence‐free survival (p < 0.001), and overall survival (p < 0.001), and significantly higher CTC counts (epithelial CTCs, epithelial/mesenchymal hybrid CTCs, and mesenchymal CTCs count, all p < 0.05) than those without EHR. Univariate and multivariate analyses revealed that EHR was associated with four risk factors in the development cohort: total CTC count (p = 0.014), tumor size (p = 0.028), node number (p = 0.045), and microvascular invasion (p = 0.035). These factors were incorporated into two nomogram models (preoperative and postoperative), which reliably predicted EHR through multidimensional verification (e.g., calibration plot, receiver operating characteristic analysis, decision curve analysis, and clinical impact curve analysis) in the development and validation cohorts, respectively. With threshold of scores of 100.3 and 176.8 before and after surgery respectively, both nomograms were able to stratify patients into two distinct prognostic subgroups (all p < 0.05). Conclusion The present study proposed two nomogram models integrating presurgical CTC counts and clinicopathological risks and showed relatively good predictive performance of EHR, which may be beneficial to the clinical practice of HCC recurrence. Further multicenter studies are needed to assess its general applicability.https://doi.org/10.1002/cam4.6178circulating tumor cells (CTC)extrahepatic recurrence (EHR)hepatic resectionhepatocellular carcinoma (HCC)prediction model
spellingShingle Hao‐Wen Wei
Shui‐Ling Qin
Jing‐Xuan Xu
Yi‐Yue Huang
Yuan‐Yuan Chen
Liang Ma
Lu‐Nan Qi
Nomograms for postsurgical extrahepatic recurrence prediction of hepatocellular carcinoma based on presurgical circulating tumor cell status and clinicopathological factors
Cancer Medicine
circulating tumor cells (CTC)
extrahepatic recurrence (EHR)
hepatic resection
hepatocellular carcinoma (HCC)
prediction model
title Nomograms for postsurgical extrahepatic recurrence prediction of hepatocellular carcinoma based on presurgical circulating tumor cell status and clinicopathological factors
title_full Nomograms for postsurgical extrahepatic recurrence prediction of hepatocellular carcinoma based on presurgical circulating tumor cell status and clinicopathological factors
title_fullStr Nomograms for postsurgical extrahepatic recurrence prediction of hepatocellular carcinoma based on presurgical circulating tumor cell status and clinicopathological factors
title_full_unstemmed Nomograms for postsurgical extrahepatic recurrence prediction of hepatocellular carcinoma based on presurgical circulating tumor cell status and clinicopathological factors
title_short Nomograms for postsurgical extrahepatic recurrence prediction of hepatocellular carcinoma based on presurgical circulating tumor cell status and clinicopathological factors
title_sort nomograms for postsurgical extrahepatic recurrence prediction of hepatocellular carcinoma based on presurgical circulating tumor cell status and clinicopathological factors
topic circulating tumor cells (CTC)
extrahepatic recurrence (EHR)
hepatic resection
hepatocellular carcinoma (HCC)
prediction model
url https://doi.org/10.1002/cam4.6178
work_keys_str_mv AT haowenwei nomogramsforpostsurgicalextrahepaticrecurrencepredictionofhepatocellularcarcinomabasedonpresurgicalcirculatingtumorcellstatusandclinicopathologicalfactors
AT shuilingqin nomogramsforpostsurgicalextrahepaticrecurrencepredictionofhepatocellularcarcinomabasedonpresurgicalcirculatingtumorcellstatusandclinicopathologicalfactors
AT jingxuanxu nomogramsforpostsurgicalextrahepaticrecurrencepredictionofhepatocellularcarcinomabasedonpresurgicalcirculatingtumorcellstatusandclinicopathologicalfactors
AT yiyuehuang nomogramsforpostsurgicalextrahepaticrecurrencepredictionofhepatocellularcarcinomabasedonpresurgicalcirculatingtumorcellstatusandclinicopathologicalfactors
AT yuanyuanchen nomogramsforpostsurgicalextrahepaticrecurrencepredictionofhepatocellularcarcinomabasedonpresurgicalcirculatingtumorcellstatusandclinicopathologicalfactors
AT liangma nomogramsforpostsurgicalextrahepaticrecurrencepredictionofhepatocellularcarcinomabasedonpresurgicalcirculatingtumorcellstatusandclinicopathologicalfactors
AT lunanqi nomogramsforpostsurgicalextrahepaticrecurrencepredictionofhepatocellularcarcinomabasedonpresurgicalcirculatingtumorcellstatusandclinicopathologicalfactors